“…At a median follow-up period of 35.2 mo (range, 5.6–62.1 mo), ten (52.6%) patients experienced disease progression and eight patients (42.1%) died. The 2-yr progression-free and overall survival was 41.2% (95% confidence interval [CI] 16.8–65.7) and 72.7% (95% CI 48.9–96.4), respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Among the study population, 71 (5.3%) died, 72 (5.4%) were transferred and the rest 1202 (89.4%) were clinically improved. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A total of 40 (18.7%) had lung involvement, 25 (11.7%) were hospitalized, 1 was admitted to the intensive care unit while none died. Favipiravir was the most prescribed drug (74.3%), followed by colchicine (40.2%), and hydroxychloroquine (20.1%) in the treatment of COVID-19. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Of the 193,454 eligible patients, 36,043 (18.6%) were hospitalized within 21 days of COVID-19 diagnosis, and 6,397 (3.3%) died. Calendar time followed an inverse J-shaped relationship where severe disease rates rapidly declined in the first 25 weeks of the pandemic. …”
Enlace del recurso
Enlace del recurso

“…A transplant candidate who ultimately died from underlying illness and COVID-19 was the only patient in the cohort who required mechanical ventilation. …”
Enlace del recurso
Enlace del recurso

“…RESULTS: Twenty-two children and 10 obstetric patients were eligible. 12 pediatric and 8 obstetric patients had moderate disease and 10 pediatric and 2 obstetric patients had severe disease. 5 pediatric patients died. 18/37 (48.6%) CCP units that were measured met FDA criteria for a high IgG titer. …”
Enlace del recurso
Enlace del recurso

“…We excluded 33 patients from the study because they either had neurologic complications or died postoperatively without discharge from the intensive care unit. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…With a median follow-up of 10.5 months (range, 1–71), 21 patients achieved complete remission, 4 had persistent disease, and 24 died. Patients younger than 65 years had longer overall survival compared to those who were ≥65 years (p = 0.0022). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A total of 99 (68.8%) patients were intubated, and 66 patients (45.8%) died. Mortality was higher, but not statistically significant, in patients with thrombotic or bleeding complications—58.6% vs. 42.6% (p-value = 0.12)—and higher in the bleeding (21.2%) vs. thrombus group (12.1%), p-value = 0.06. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…At a median follow-up of 41 months, 25 patients (23.6%) had died or had tumor recurrence and metastasis. The optimal cutoff value for the CONUT score was 3, and a lower CONUT score was associated with the Fuhrman grade (P=0.024). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…One patient with probable autoimmune rhombencephalitis died despite immune therapy. The remaining 26 encephalopathy cohort patients had toxic-metabolic diagnoses. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A total of six patients died during the study or study follow‐up period (one [<1%] patient in the voclosporin group and five [3%] patients in the placebo group). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Ten of 86 (9%) neonates in the ESG and 4 of 86 (4%) in the CSG died before the 2-year assessment. The odds of the primary outcome were not significantly different in the ESG group compared with the CSG group (ESG, 38 of 86 [44%] vs CSG, 27 of 86 [31%]; odds ratio [OR], 1.83; 95% CI, 0.96 to 3.49; P = .14). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All patients started on ABx (ceftriaxone/co-amoxiclav/piptazo/carbapenems/levofloxacin) for CA ARI & PCT < 0.5µg/L were analysed. Those who died ≤48h of admission; admitted to intensive care; required ABx escalation; >1 infective sites; complex lung infection were excluded. …”
Enlace del recurso
Enlace del recurso

“…Total disability-adjusted life years (DALYs) for 28 patients with PNS were 472.7 years, based on total years of life lost (YLL) for patients dying between 1987 and 2018 (n = 15) of 445.3 years plus years lived with disability (YLD) 27.4 years. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The mean age at surgery was 61.6 +- 10.0 years (range 38.7-84.3). Four patients died with their initial implants in place. The mean duration of follow up for living patients that retained both initial components at final follow-up was 6.2 +- .9 years (range 4.7-8.1 years). 35% (26 of 74) of ankles had a preoperative coronal plane deformity of at least 10 degrees. 11% (8 of 74) of the ankles had a preoperative coronal plane deformity of at least 20 degrees. …”
Enlace del recurso
Enlace del recurso

“…As for the WHO COVID-19 severity classification, 19 (63.3%) SOT recipients were mild, nine (30%) were moderate, and two were critical and died yielding a crude mortality rate in our patient population of 6.7%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Sadly, one 70-year-old female patient with heart and lung disease died after 17 days in ICU and 22 days in the hospital. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A total of 8.8% of the newborns experienced significant morbidity, with the lowest prevalence among infants delivered by women in the normal weight BMI class (8.0%) and the highest among infants delivered by women with class 3 obesity (12.4%); 0.34% of infants died within 1 year of birth, with the lowest prevalence among infants delivered by women in the normal weight BMI class (0.28%) and the highest among infants delivered by women with class 3 obesity (0.58%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Seventy-three patients died of uncontrolled brain metastases at a median of 12 months. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso